Search Results - "ALLHAT Collaborative Research Group"

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

Authors: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack trial Collaborative Research Group ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Source: JAMA: Journal of the American Medical Association. 12/18/2002, Vol. 288 Issue 23, p2998-3007. 10p.

URL: 8688386

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Source: JAMA: Journal of the American Medical Association. 12/18/2002, Vol. 288 Issue 23, p2981-2997. 17p.

URL: 8688392

Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: Muntner, Paul Davis, Barry R Cushman, William C et al.

Source: Hypertension (0194911X). Nov2014, Vol. 64 Issue 5, p1012-1021.

Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex.

Authors: Oparil, Suzanne Davis, Barry R Cushman, William C et al.

Source: Hypertension (0194911X). May2013, Vol. 61 Issue 5, p977-986.

Clinical and demographic correlates of medication and visit adherence in a large randomized controlled trial.

Authors: Whittle, Jeff Yamal, José-Miguel Williamson, Jeffrey D. et al.

Source: BMC Health Services Research. 7/8/2016, Vol. 16, p1-11. 11p. 3 Charts.

Benazepril plus amlodipine or hydrochlorothiazide for hypertension.

Authors: Davis BR Whelton PK ALLHAT Collaborative Research Group

Source: New England Journal of Medicine. 3/12/2009, Vol. 360 Issue 11, p1148-1150. 3p.

Rapid eGFR change as a determinant of cardiovascular and renal disease outcomes and of mortality in hypertensive adults with and without type 2 diabetes.

Authors: Barzilay, Joshua I. Davis, Barry R. Ghosh, Alokananda et al.

Source: Journal of Diabetes & its Complications. Sep2018, Vol. 32 Issue 9, p830-832. 3p.

Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]).

Authors: Alderman, Michael H Davis, Barry R Piller, Linda B et al.

Source: American Journal of Cardiology. 1/1/2016, Vol. 117 Issue 1, p105-115. 11p.

Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

Authors: Margolis, Karen L Davis, Barry R Baimbridge, Charles et al.

Source: Journal of Clinical Hypertension. Aug2013, Vol. 15 Issue 8, p542-554. 13p.

Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)

Authors: Haywood LJ Ford CE Crow RS et al.

Source: Journal of the American College of Cardiology (JACC). Nov2009, Vol. 54 Issue 22, p2023-2031. 9p.

Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

Authors: Whelton PK Barzilay J Cushman WC et al.

Source: Archives of Internal Medicine. 6/27/2005, Vol. 165 Issue 12, p1401-1409. 9p.

URL: 17457034

ALLHAT: setting the record straight.

Authors: Davis, Barry R. Furberg, Curt D. Wright Jr., Jackson T. et al.

Source: Annals of Internal Medicine. 7/6/2004, Vol. 141 Issue 1, p39-46. 8p.

Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial.

Authors: Davis BR Cutler JA Furberg CD et al.

Source: Annals of Internal Medicine. 9/3/2002, Vol. 137 Issue 5, p313-320. 8p.

URL: 7266823

Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: Barzilay, Joshua I. Jones, Cheryl L. Davis, Barry R. et al.

Source: Diabetes Care. Apr2001, Vol. 24 Issue 4, p654-658. 5p. 1 Diagram, 1 Chart.

Chlorthalidone versus hydrochlorothiazide.

Authors: Einhorn, Paula T Cushman, William C Whelton, Paul K et al.

Source: Annals of Internal Medicine. 6/18/2013, Vol. 158 Issue 12, p922-923. 2p.

Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT.

Authors: Bangalore, Sripal Davis, Barry R. Cushman, William C. et al.

Source: American Journal of Medicine. Apr2017, Vol. 130 Issue 4, p439-448.e9. 1p.

Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project.

Authors: Bartholomew LK Cushman WC Cutler JA et al.

Source: Clinical trials (London, England) [Clin Trials] 2009 Aug; Vol. 6 (4), pp. 329-43. Date of Electronic Publication: 2009 Jul 08.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 101197451 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1740-7753 (Electronic) Linking ISSN: 17407745 NLM ISO Abbreviation: Clin Trials Subsets: MEDLINE

Real-world evidence supports optimally dosed thiazide-type diuretics as preferred in treatment regimens of older adults with hypertension.

Authors: Einhorn PT Whelton PK Davis BR et al.

Source: Journal of the American Geriatrics Society [J Am Geriatr Soc] 2015 May; Vol. 63 (5), pp. 1045-7.

Publication Type: Letter; Research Support, N.I.H., Extramural; Comment

Journal Info: Publisher: Blackwell Science Country of Publication: United States NLM ID: 7503062 Publication Model: Print Cited Medium: Internet ISSN: 1532-5415 (Electronic) Linking ISSN: 00028614 NLM ISO Abbreviation: J Am Geriatr Soc Subsets: MEDLINE